ttax03

Small moleculeexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Oct 31, 2021 (NCT05079035)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06780306Phase 2Dec 12, 2024BioTissue Holdings, Inc
NCT06236308Phase 1Jul 15, 2024BioTissue Holdings, Inc
NCT05079035Phase 2Oct 31, 2021Tissue Tech Inc.
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
BioTissue Holdings, IncFor profit2222024
Tissue Tech Inc.For profit1112021
2 organizations
Page 1 / 1